For instance, mutations in genes like ACTN2, CACNA1C, and CALR3 have been identified as pathogenic, implicating them in conditions like HCM, DCM, LQTS, familial HCM, and ARVC. This evidence concerns the gene ACTN2 and familial long QT syndrome.